References
- OverboschDSchilthuisHBienzleRHAtovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind studyClin Infect Dis20013371015102111528574
- LoutanLMalaria: still a threat to travellersInt J Antimicrob Agents200321215816312615380
- LederKBlackJO’BrienDMalaria in travelers: a review of the GeoSentinel surveillance networkClin Infect Dis200415:3981104111215486832
- JacqueriozFACroftAMDrugs for preventing malaria in travellersCochrane Database Syst Rev20094CD00649119821371
- SchlagenhaufPAdamcovaMRegepLSchaererMTRheinHGThe position of mefloquine as a 21st century malaria chemoprophylaxisMalar J2010935721143906
- World Health OrganizationThe Importance of Pharmacovigilance: Safety monitoring of medicinal productsSwitzerland, GenevaWHO2002
- TalisunaAOStaedkeSGD’AlessandroUPharmacovigilance of antimalarial treatment in Africa: is it possible?Malar J200655016780575
- ICTDR (International Centre for Tropical Diseases)Investigator manualMonitoring and reporting adverse events2005 Available from: http://www.icssc.org/Documents/Resources/ICTDR_AE_Manual_February_6_2003_final.pdfAccessed May 12, 2012
- WHOA Practical Handbook on the Pharmacovigilance of Medicines used in the Treatment of Tuberculosis: Enhancing the safety of the TB patientGeneva, SwitzerlandWHO2002
- SinghKShanksGDWildeHSeizures after mefloquineAnn Intern Med1991114119942024874
- CDC (Centers for Disease Control and Prevention)Pregnant travellers2012 Available from: http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-8-advising-travelers-with-specific-needs/pregnant-travelers.htmAccessed May 3, 2012
- HoebeCde MunterJThijsCAdverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxisEur J Clin Pharmacol19975242692759248763
- HennequinCBoureePBazinNBisaroFFelineASevere psychiatric side effects observed during prophylaxis and treatment with mefloquineArch Int Med1994154236023627944858
- WellsTSSmithTCSmithBMefloquine use and hospitalizations among US service members, 2002–2004Am J Trop Med Hyg200674574474916687673
- NevinRLMefloquine prescriptions in the presence of contraindications: prevalence among US military personnel deployed to Afghanistan, 2007Pharmacoepidem Drug Safe201019206210
- KuemmerleADodooANOlssonSVan ErpsJBurriCLalvaniPSAssessment of global reporting of adverse drug reactions for antimalarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug MonitoringMalar J2011105721388536
- WHOIntroductory Guide MedDRA Version 14.02011 MSSO-DI-6003-14.0.0. Available from: http://www.who.int/medical_devices/innovation/MedDRAintroguide_version14_0_March.2011.pdfAccessed May 3, 2012
- BateAEvansSJWQuantitative signal detection using spontaneous ADR reportingPharmacoepidem. Drug Safe200918427436
- BarrettPJEmminsPDClarkePDBradleyDJComparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellersBMJ199631370565255288789977
- SchalgenhaufPTschoppAJohnsonFTolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm studyBMJ20033277423107814604928
- OhrtCRichieTLWidjajaHMefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiersAnn Intern Med1997126129639729182474
- ArthurJDEcheverriaPShanksGDKarwackiJLadapornBBrownJEA comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxisAm J Trop Med Hyg19904366086132267964
- WalshLIncidental events in spontaneous reports-a proposal for filtering noiseBr J Clin Pharmacol200561111811916390361
- LevineJGTonningJMSzarfmanAReply: The evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learnedBr J Clin Pharmacol200561110511316390358
- EdwardsRAn agenda for UK clinical pharmacology pharmacovigilanceBr J Clin Pharmacol201273697998222360774
- AliAKHartzemaAGAssessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reportingJ Asthma Allergy2012511922690127
- WilsonAMThabaneLHolbrookAApplication of data mining techniques in pharmacovigilanceBr J Clin Pharmacol200457212713414748811
- LokeYKDerrySAronsonJKA comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodaroneBr J Clin Pharmacol20045761662115089815
- ArnaizJACarnéXRibaNCodinaCRibasJTrillaAThe use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawalsEur J Clin Pharmacol2001571899111372600
- HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated Mar 2011]The Cochrane Collaboration2011 Available from http://www.cochranehandbook.orgAccessed May 12, 2012
- GaylordKMThe psychosocial effects of combat: the frequently unseen injuryCrit Care Nurs Clin North Am200618334935716962456
- van PuijenbroekEPvan GrootheestKDiemontWLLeufkensHGEgbertsACDeterminants of signal selection in a spontaneous reporting system for adverse drug reactionsBr J Clin Pharmacol200152557958611736867
- JavorskyDJTremontGKeitnerGIParmentierAHCognitive and neuropsychiatric side effects of mefloquineJ Neuropsychiatry Clin Neurosci20011330230211449039
- NostenFter KuileFMaelankiriLMefloquine prophylaxis prevents malaria during pregnancy: a double blind, placebo controlled studyJ Infect Dis19941695956038158032